Research Site
Bremen 28755
2 studies enrolling now · 10 studies all time
What they study most
Acute Coronary Syndrome, Acute Intracranial Hemorrhage, Anemia, Breast Cancer, COPD, COPD (Chronic Obstructive Pulmonary Disease), Cardiovascular Disease, Congestive Heart Failure, Heart Failure, Metastatic Castration-resistant Prostate Cancer, Ventricular Dysfunction
Studies at this site
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease — Recruiting now
- Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling
- Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer — Running, not enrolling
- Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor — Completed
- Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) — Completed
- Long-term Observational Study of the Safety of Roflumilast — Completed
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial — Completed
- Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed